Abiopharma

DXCM Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against DexCom, Inc. (DXCM)

Give Your Back a Break this Holiday with The Joint Chiropractics "Back Friday Deals"

Raphael Pharmaceutical Announces Filing of Provisional Patent Application for the Treatment of Neutrophil-Dominant Autoimmune Diseases, Including Rheumatoid Arthritis (RA)

Incyte gibt positive CHMP-Stellungnahme zu Minjuvi® (Tafasitamab) für das rezidivierte oder refraktäre follikuläre Lymphom (FL) bekannt

Deadline Approaching: Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

Incyte annonce l’avis favorable du CHMP concernant Minjuvi® (tafasitamab) pour le traitement du lymphome folliculaire (LF) récidivant ou réfractaire

CYTK FINAL DEADLINE: Faruqi & Faruqi, LLP Announces that Cytokinetics Investors Have Opportunity to Lead Class Action Lawsuit

Scynexis Announces Federal Funding of Collaboration Between Hackensack Meridian CDI and Johns Hopkins Researchers to Develop New Therapeutics, Including Novel Fungerps, for Resistant Fungal Infections

Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm

MLTX DEADLINE REMINDER: Berger Montague Reminds MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors of Important Class Action Lawsuit Deadline